Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Aytu Biopharma stock
Learn how to easily invest in Aytu Biopharma stock.
Aytu Biopharma Inc is a drug manufacturers-specialty & generic business based in the US. Aytu Biopharma shares (AYTU) are listed on the NASDAQ and all prices are listed in US Dollars. Aytu Biopharma employs 175 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Aytu Biopharma
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AYTU – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Aytu Biopharma stock price (NASDAQ: AYTU)Use our graph to track the performance of AYTU stocks over time.
Aytu Biopharma shares at a glance
|Latest market close||$1.28|
|52-week range||$1.31 - $11.76|
|50-day moving average||$1.80|
|200-day moving average||$3.77|
|Wall St. target price||$17.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-4.07|
Buy Aytu Biopharma shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Aytu Biopharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Aytu Biopharma price performance over time
|1 week (2022-01-11)||-11.11%|
|1 month (2021-12-17)||-20.00%|
|3 months (2021-10-18)||-49.61%|
|6 months (2021-07-19)||-69.30%|
|1 year (2021-01-19)||-83.29%|
|2 years (2020-01-17)||60.00%|
|3 years (2019-01-18)||21.90%|
|5 years (2017-01-19)||15.32%|
Aytu Biopharma financials
|Revenue TTM||$74 million|
|Gross profit TTM||$29.2 million|
|Return on assets TTM||-14.54%|
|Return on equity TTM||-80.8%|
|Market capitalisation||$38 million|
TTM: trailing 12 months
Aytu Biopharma share dividends
We're not expecting Aytu Biopharma to pay a dividend over the next 12 months.
Have Aytu Biopharma's shares ever split?
Aytu Biopharma's shares were split on a 1:10 basis on 8 December 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aytu Biopharma shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Aytu Biopharma shares which in turn could have impacted Aytu Biopharma's share price.
Aytu Biopharma share price volatility
Over the last 12 months, Aytu Biopharma's shares have ranged in value from as little as $1.31 up to $11.76. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aytu Biopharma's is -0.3654. This would suggest that Aytu Biopharma's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Aytu Biopharma has bucked the trend.
Aytu Biopharma overview
Aytu Biopharma, Inc. , a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021.
Aytu Biopharma in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Frequently asked questionsWhat percentage of Aytu Biopharma is owned by insiders or institutions?
Currently 6.271% of Aytu Biopharma shares are held by insiders and 17.707% by institutions. How many people work for Aytu Biopharma?
Latest data suggests 175 work at Aytu Biopharma. When does the fiscal year end for Aytu Biopharma?
Aytu Biopharma's fiscal year ends in June. Where is Aytu Biopharma based?
Aytu Biopharma's address is: 373 Inverness Parkway, Englewood, CO, United States, 80112 What is Aytu Biopharma's ISIN number?
Aytu Biopharma's international securities identification number is: US0547548745 What is Aytu Biopharma's CUSIP number?
Aytu Biopharma's Committee on Uniform Securities Identification Procedures number is: 054754106
More guides on Finder
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Can Turo’s IPO do better than Uber and Airbnb?
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
Ask an Expert